Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
15.7%
% of BMED's 140 holdings also in FBT
66.7%
% of FBT's 31 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 2.6% | 2.9% | 2.6% |
|
AMGEN INC | 2.5% | 2.8% | 2.5% |
 |
ARGENX SE ADR | 2.4% | 3.8% | 2.4% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.4% | 3.0% | 2.4% |
|
BIOMARIN PHARMACEUTICAL INC | 1.9% | 3.2% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to FBT
|
BOSTON SCIENTIFIC CORP | 3.7% |
|
AMERISOURCEBERGEN CORP | 3.4% |
|
INTUITIVE SURGICAL INC | 2.8% |
|
WEST PHARMACEUTICAL SERVICES | 2.3% |
|
DANAHER CORP | 2.0% |
|
BIO-TECHNE CORPORATION | 1.9% |
|
QIAGEN NV | 1.8% |
|
MCKESSON CORP | 1.7% |
|
UNITEDHEALTH GROUP INC | 1.6% |
|
THERMO FISHER SCIENTIFIC INC | 1.6% |
BMED Underweight Relative to FBT
|
CORCEPT THERAPEUTICS INC | -4.1% |
|
ACADIA PHARMACEUTICALS INC | -3.9% |
|
EXELIXIS INC | -3.9% |
|
NATERA INC | -3.7% |
|
INTRA-CELLULAR THERAPIES INC | -3.7% |
|
GILEAD SCIENCES INC | -3.6% |
|
CATALYST PHARMACEUTICAL PART | -3.6% |
 |
BIONTECH SE SPONSORED ADR | -3.4% |
|
ILLUMINA INC | -3.3% |
 |
ALKERMES PLC | -3.3% |